GGrantIndex
← Leaderboards

Women And Infants Hospital-Rhode Island

Providence, RI

Compare ↔
$196,513,246
Total funding
179
Grants

Funding over time

peak $16.8M · FY200525
$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$193,394,107 · 174
CDC$1,890,185 · 3
AHRQ$1,228,954 · 2

By mechanism

R01$72,352,217 · 35
P20$28,855,303 · 75
UH3$24,873,338 · 2
U10$23,904,319 · 5
UG1$7,887,554 · 3
K12$6,508,425 · 2

Investigators at Women And Infants Hospital-Rhode Island

Largest grants

The Developing Brain: Influences and Outcomes$4,831,711
UH3 · FY2018 · OD
ENVIRONMENTAL INFLUENCES ON NEURODEVELOPMENTAL OUTCOME IN INFANTS BORN VERY PRETERM$4,245,455
UH3 · FY2019 · OD
ENVIRONMENTAL INFLUENCES ON NEURODEVELOPMENTAL OUTCOME IN INFANTS BORN VERY PRETERM$3,924,809
UH3 · FY2018 · OD
ENVIRONMENTAL INFLUENCES ON NEURODEVELOPMENTAL OUTCOME IN INFANTS BORN VERY PRETERM$3,899,402
UH3 · FY2022 · OD
ENVIRONMENTAL INFLUENCES ON NEURODEVELOPMENTAL OUTCOME IN INFANTS BORN VERY PRETERM$3,668,723
UG3 · FY2017 · OD
ENVIRONMENTAL INFLUENCES ON NEURODEVELOPMENTAL OUTCOME IN INFANTS BORN VERY PRETERM$3,299,402
UH3 · FY2021 · OD
ENVIRONMENTAL INFLUENCES ON NEURODEVELOPMENTAL OUTCOME IN INFANTS BORN VERY PRETERM$2,869,781
UH3 · FY2020 · OD
COBRE for Reproductive Health$2,498,535
P20 · FY2017 · GM
COBRE for Reproductive Health$2,483,917
P20 · FY2018 · GM
COBRE for Reproductive Health$2,463,931
P20 · FY2019 · GM
COBRE for Reproductive Health$2,419,527
P20 · FY2020 · GM
COBRE for Reproductive Health$2,366,668
P20 · FY2021 · GM
COBRE for Perinatal Biology$2,125,766
P20 · FY2010 · RR
COBRE for Perinatal Biology$2,104,517
P20 · FY2012 · GM
COBRE for Perinatal Biology$2,104,510
P20 · FY2011 · RR
COBRE for Perinatal Biology$2,063,846
P20 · FY2009 · RR
COBRE for Perinatal Biology$2,051,183
P20 · FY2008 · RR
COBRE for Perinatal Biology$1,901,101
P20 · FY2003 · RR
COBRE for Perinatal Biology$1,736,905
P20 · FY2004 · RR
The Developing Brain: Influences and Outcomes$1,672,732
UH3 · FY2019 · OD